A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease
一种新型甘氨酸转运蛋白-1 (GlyT1) 抑制剂 ASP2535（4-[3-异丙基-5-(6-苯基-3-吡啶基)-4H-1,2,4-三唑-4-基]-2,1,3-苯并恶二唑）可改善精神分裂症和阿尔茨海默病认知障碍动物模型的认知能力
期刊:European Journal of Pharmacology
影响因子:4.2
doi:10.1016/j.ejphar.2012.04.013
Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu, Mayako Yamazaki, Masahiko Morita, Shinji Takahashi, Masaki Aota, Kyoko Saita, Hitoshi Doihara, Yuichiro Sato, Takayuki Yamaji, Keni Ni, Nobuya Matsuoka
